Business Wire

Torq Announces 300% Revenue Growth and 200% Employee Growth as Torq’s AI-Powered SOC and Agentic AI Security Solutions Achieve Fortune 500 Customer Traction

Share

Torq Also Appoints Veteran Sales Leader Usman Gulfaraz as VP of EMEA Sales and Opens New EMEA Headquarters in London

Torq, the autonomous security operations leader, today announced that in 2024, it achieved 300% revenue growth and 200% employee growth. Torq is also expanding operations across EMEA, opening new EMEA headquarters in London, and appointing Usman Gulfaraz as its new VP of EMEA Sales. Torq’s EMEA momentum mirrors the tremendous growth it experienced in 2024 across North and South America, and APAC, where Torq HyperSOC and Torq Hyperautomation products are now firmly established as the premiere Agentic AI and autonomous SOC solutions of choice for the Fortune 500. These announcements follow Torq’s recent closing of its $70M Series C round, which brought its total funding to $192M. For 2026, Torq has established an aggressive ARR target of $100M, which includes EMEA revenue.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250128254651/en/

Torq's EMEA Headquarters in London (Photo: Business Wire)

Gulfaraz is a revered sales veteran who was most recently responsible for global revenue at Speechmatics. Previously, he ran EMEA for Tessian, which he helped lead to acquisition by Proofpoint. Prior to that, he ran EMEA for Shape Security which he helped lead to acquisition by F5. Torq has also appointed Jaicee Matthews as its Head of EMEA Marketing. Matthews previously led marketing teams for GTT, Edgio, and Lumen Technologies. Gulfarez and Matthews are based in Torq’s new London headquarters. Sheldon Muir, Head of Global Channels and Alliances, is managing the EMEA partner ecosystem from Torq’s New York City worldwide headquarters.

“We’re seeing extraordinary enterprise demand for Torq’s Agentic AI security solutions across EMEA,” said Gulfaraz. “Organizations understand the incredible results Torq is delivering for multinational companies. They’ve seen how our technology transformed the cybersecurity landscape during 2024, with the introduction of the expanded Torq HyperSOC featuring our Agentic AI Multi-Agent Framework. And now they’re eager to deploy these solutions to enhance their own security operations. Torq officially brought the SOAR era to a close last year. In 2025, the sky’s the limit for Torq as it continues to rapidly evolve into a global force.”

Torq’s customer base includes some of the biggest names in cybersecurity, consumer packaged goods, industrial automation, online services, retail, and telecommunications, such as Check Point Security, Chipotle Mexican Grill, Inditex (Zara, Bershka, and Pull & Bear), Informatica, PepsiCo, Procter & Gamble, Siemens, Telefonica, Wiz, and World Economic Forum.

“Today, Torq HyperSOC investigates, triages, and remediates many of Check Point’s internal security alerts without any human intervention,” said Jonathan Fischbein CISO, Check Point. “If an alert meets certain parameters based on organizational security policies, the platform takes relevant predefined steps, such as initiating an MFA challenge or locking out a suspicious user. We can react automatically to problems before they become security incidents.”

Torq’s ever-expanding EMEA partner base includes AdvanceSec, Bytes Software Services, Check Point, GlobalDots, Nubera, Nueva Group, Softcat, Tata Group, Wiz, and WWT.

“We are thrilled to partner with Torq and continue to deliver innovation that matters to our customers,” said Adam McCaig, Head of Security Strategy and Services, Bytes Software Services. “Demand for Torq’s game-changing Hyperautomation Platform and Torq HyperSOC continues expanding exponentially. Together, Torq and Bytes Software Services are making enterprise SecOps teams across EMEA more productive and focused with their AI-driven SecOps and autonomous SOC solutions, ensuring organizations can mitigate existential security issues before they have a chance of creating adverse impacts.”

Learn more about Torq at Torq.io.

About Torq

Torq is transforming cybersecurity with its agentic AI security operations solutions. Torq empowers enterprises to instantly and precisely detect and respond to security events at scale. Fortune 500 companies, including the world’s biggest financial, technology, consumer packaged goods, fashion, hospitality, and sports apparel organizations are experiencing extraordinary outcomes with Torq.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250128254651/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release

- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release

With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp

Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release

The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev

7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release

MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release

Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye